Klinické studie

Přehled klinických studií a odborných publikací

• Algoritmus diagnostiky a léčby osteoporózy/ Farmakoterapeutické postupy/ Farmakoterapie 5/2005 [PDF/325kB]


• Nové perspektivy v léčbě osteoporózy/ Nové trendy ve farmakoterapii/ Farmakoterapie 5/2005 [PDF/144kB]


• Factors associated with adherence and persistence to bisphosphonate therapy in osteoporosis: a cross-sectional survey [PDF/136kB]


• Effects of Oral Ibandronate Administered Daily or Intermittently on Fracture Risk in Postmenopausal Osteoporosis [PDF/194kB]


• Compliance with drug therapy for postmenopausal osteoporosis [PDF/209kB]


• Rationale and design of the MOTION study (Monthly Oral Therapy with Ibandronate for Osteoporosis iNtervention) [PDF/15kB]


• Rationale and design of the MOTION study (Monthly Oral Therapy with Ibandronate for Osteoporosis iNtervention) - poster [PDF/32kB]


• Intravenous Ibanronate Injections in Postmenopausal Woman With Osteoporosis [PDF/1667kB]


• Two-year efficacy and tolerability of intermittent intravenous ibandronate injections in postmenopausal osteoporosis: the DIVA study [PDF/39kB]


• Patient preference for once-monthly ibandronate versus once-weekly alendronate in a randomized, openlabel, cross-over trial: the Boniva Alendronate Trial in Osteoporosis (BALTO) [PDF/534kB]


• Ibantronate Reduces Clinical and Nonvertebral Fracture Risk in Women with Postmenopausal OsteoporosisS (PMO): Results of a A Pooled Analysis of Clinical Trials [PDF/23kB]


• Monthly Oral Ibandronate Therapy in Postmenopausal Osteoporosis: 1-Year Results From the MOBILE Study [PDF/127kB]


• Treatment persistence with once-monthly ibandronate and patient support vs. once-weekly alendronate: results from the PERSIST study [PDF/144kB]


• Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporopis: 2 year results from MOBILE study [PDF/1411kB]